Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19

NCT04568863 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV 2
Coronavirus Infection

Interventions

DRUG: Melatonin intravenous
DRUG: Placebo intravenous

Sponsor

Pharmamel S.L.

Collaborators

[object Object]
[object Object]